Enter inventor name

Walter Peris

USPTO Granted Patents = 15 (Patent Applications = 1)

CIPO Patents = 1

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 44(Granted Patents)

Location History:

Milano, IT (1990 - 1992)
Milan, IT (1989 - 2010)

Company Filing History:

13 out of 33

Rotta Research Laboratorium

patents

1 out of 1

Rotta Research Laborarorium S.p.a.

Years Active: 1989-2010

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7824710 - Crystalline and stable form of andolast (2010-11-02),

2. 6605722 - Tyrosine derivatives with anti-leukotrienen activity (2003-08-12),

3. 6075033 - Anthranilic acid diamides derivatives, their preparation and (2000-06-13),

4. 5985885 - Quinazoline-4-amino-2-(piperidine-1-yl-4-substituted) derivatives having (1999-11-16),

5. 5962502 - Polyamidic acid derivatives with antigastrin activity, a method for (1999-10-05),

6. 5922875 - Aromatic acid diamides with antigastrin activity, a method for their (1999-07-13),

7. 5723494 - Derivatives of glutamic and aspartic acids, a method of preparing them, (1998-03-03),

8. 5602179 - Optically-active derivatives of (R) 5-pentylamino-5-oxopentanoic acid (1997-02-11),

9. 5391574 - Optically-active derivatives of (R) 5-pentylamino-5-oxopentanoic acid (1995-02-21),

10. 5232937 - Derivatives of N-phenylbenzamide with anti-ulcer and anti-allergy (1993-08-03),

11. 5130474 - Optically-active derivatives of (R) 5-pentylamino-5-oxopentanoic acid (1992-07-14),

12. 4895856 - Derivatives of 5-pentylamino-5-oxopentanoic and (1990-01-23),

13. 4891383 - Derivatives of 5-pentylamino-5-oxopentanoic and (1990-01-02),

14. 4891381 - Derivatives of 5-pentylamino-5-oxopentanoil and (1990-01-02),

15. 4826878 - New derivatives of 5-pentylamino-5-oxopentanoic and (1989-05-02),

Title: Walter Peris: Innovator in Pharmaceutical Chemistry

Introduction

Walter Peris is a distinguished inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 15 patents. His work focuses on developing stable and effective pharmaceutical compounds, which are crucial for the industry.

Latest Patents

Among his latest patents is the invention of a crystalline and stable form of Andolast. This new crystalline Form A of Andolast disodium salt is triclinic and displays a thermal event at 98-112°C, melting with decomposition at about 400°C as determined by differential scanning calorimetry (DSC). Notably, Andolast disodium Form A is a non-hygroscopic solid, demonstrating surprising stability under various humidity conditions, making it suitable for ordinary storage. This stability enhances both chemical and pharmaceutical manufacturing processes, allowing for consistency and reproducibility in conditions that are more viable and cost-effective compared to those required for highly hygroscopic solids. Additionally, he has worked on tyrosine derivatives with anti-leukotriene activity, further showcasing his innovative approach to pharmaceutical development.

Career Highlights

Walter Peris has had a notable career, contributing to advancements in pharmaceutical chemistry. His work has been instrumental in developing compounds that improve the efficacy and stability of medications.

Collaborations

Throughout his career, he has collaborated with esteemed colleagues such as Francesco Makovec and Luigi A. Rovati. He has also been associated with Rotta Research Laboratorium S.p.a. and Rotta Research Laboratorium, where he has furthered his research and development efforts.

Conclusion

Walter Peris is a prominent figure in the field of pharmaceutical chemistry, with a strong portfolio of patents that reflect his innovative spirit. His contributions continue to impact the industry positively, paving the way for more effective and stable pharmaceutical products.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com